Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges. | J Enzyme Inhib Med Chem | 2022 | 35702041 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of a novel series of 2-(2,6-dioxopiperidin-3-yl)isoquinoline-1,3(2H,4H)-dione derivatives as cereblon modulators. | J Enzyme Inhib Med Chem | 2022 | 35698881 | PubTator, text mining | PubMed |
| Double-drug loading upconversion nanoparticles for monitoring and therapy of a MYC/BCL6-positive double-hit diffuse large B-cell lymphoma. | Biomaterials | 2022 | 35696785 | PubTator, text mining | PubMed |
| Discovery of highly potent and selective CRBN-recruiting EGFRL858R/T790M degraders in vivo. | Eur J Med Chem | 2022 | 35691176 | PubTator, text mining | PubMed |
| Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. | Molecules | 2022 | 35684392 | PubTator, text mining | PubMed |
| Molecular Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis. | Int J Mol Sci | 2022 | 35683015 | PubTator, text mining | PubMed |
| Molecular Glues: Capable Protein-Binding Small Molecules That Can Change Protein-Protein Interactions and Interactomes for the Potential Treatment of Human Cancer and Neurodegenerative Diseases. | Int J Mol Sci | 2022 | 35682885 | PubTator, text mining | PubMed |
| Stabilization of CDK6 by ribosomal protein uS7, a target protein of the natural product fucoxanthinol. | Commun Biol | 2022 | 35681048 | PubTator, text mining | PubMed |
| PROTACs: great opportunities for academia and industry (an update from 2020 to 2021). | Signal Transduct Target Ther | 2022 | 35680848 | PubTator, text mining | PubMed |
| CD147 a direct target of miR-146a supports energy metabolism and promotes tumor growth in ALK+ ALCL. | Leukemia | 2022 | 35676454 | PubTator, text mining | PubMed |
| Exploring Degradation of Mutant and Wild-Type Epidermal Growth Factor Receptors Induced by Proteolysis-Targeting Chimeras. | J Med Chem | 2022 | 35675209 | PubTator, text mining | PubMed |
| PROTACs: past, present and future. | Chem Soc Rev | 2022 | 35671157 | PubTator, text mining | PubMed |
| Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells. | J Cell Biol | 2022 | 35670764 | PubTator, text mining | PubMed |
| The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma. | Transl Oncol | 2022 | 35660848 | PubTator, text mining | PubMed |
| Perspectives on the Risk-Stratified Treatment of Multiple Myeloma. | Blood Cancer Discov | 2022 | 35653112 | PubTator, text mining | PubMed |
| A Temporal PROTAC Cocktail-Mediated Sequential Degradation of AURKA Abrogates Acute Myeloid Leukemia Stem Cells. | Adv Sci (Weinh) | 2022 | 35652200 | PubTator, text mining | PubMed |
| Persister state-directed transitioning and vulnerability in melanoma. | Nat Commun | 2022 | 35650266 | PubTator, text mining | PubMed |
| A direct high-throughput protein quantification strategy facilitates discovery and characterization of a celastrol-derived BRD4 degrader. | Cell Chem Biol | 2022 | 35649410 | PubTator, text mining | PubMed |
| Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells. | Front Oncol | 2022 | 35646666 | PubTator, text mining | PubMed |
| Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence. | Leukemia | 2022 | 35643867 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=59